Latest filing published 21 Dec 2015 for ZS Pharma, Inc., €83k.
No signal scores available.
John M. Whiting has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Genentech Inc and ZS Pharma, Inc. Between 18 January 2007 and 17 December 2015, the trades on record add up to 101 filings.
Sales make up the whole of the open-market record (50 sales, €3.7M). Other entries cover 50 option exercises.
The newest entry dates from 21 December 2015: a transaction of €83k, in ZS Pharma, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 85 declarations